ADHD Medication and Height: Does It Affect Growth?

Child Health

Our growth velocity guide explains how to tell whether a child is growing at a healthy pace, and our guide on when to worry about a child's height covers the warning signs of growth failure in general. This piece answers a narrower question many parents ask before or during ADHD treatment: do stimulant medications slow growth, and do they change how tall a child ends up as an adult? It covers why the concern exists, what the long-term studies actually found, where they disagree, and what monitoring looks like in practice.

How Much Height Difference Have Long-Term Studies Found?

Height gaps reported for children treated with stimulants, from the two largest long-term follow-ups

MTA study comparisons (cm shorter) Rochester population-based cohort
Reading the chart: each bar is a separate comparison, not a running total, and the bars should not be added together. The 3-year figure is the childhood growth difference described in FDA methylphenidate labeling, drawn from the MTA study. The two "adult" bars come from the MTA follow-up at about age 25 (reference 1), and the 16-year bar from a later growth-trajectory analysis of the same study (reference 2). MTA medication groups were self-selected by families after the original trial ended, so the comparisons are observational. The Rochester bar reflects a population-based birth cohort that found no significant difference in adult height (reference 3). See references 1 to 3 and 5 below.

Why Doctors Watch Growth on ADHD Medication

🍽️
Appetite Suppression

Decreased appetite and reduced weight gain are listed side effects of stimulant medications. Eating less during the day is the most widely cited explanation for slower growth, especially early in treatment.

🧠
A Possible Hormone Effect

Stimulants raise dopamine levels in the brain, and researchers have proposed that this may briefly affect growth hormone signaling. This mechanism is a hypothesis rather than an established explanation.

Concern about stimulants and growth dates back to studies in the 1970s, and it is serious enough that FDA prescribing information for methylphenidate includes a specific warning about long-term suppression of growth. The label tells prescribers to closely monitor height and weight in children taking stimulants and notes that a child who is not growing or gaining weight as expected may need treatment interrupted. That is a monitoring instruction, not a reason to avoid treatment, and it is the foundation for how most pediatricians handle the issue.

What the Research Shows in the First Few Years

The clearest and most consistent finding is a modest slowdown early in treatment. Here is the pattern the evidence describes.

💊
Stimulant Treatment Starts

Methylphenidate or an amphetamine-based medication

→
⚖️
Weight Gain Slows First

The biggest weight effect appears in the first 12 months

→
📏
Height Gain Dips

Concentrated in the first 24 to 30 months

→
❓
Adult Height: Unsettled

Long-term studies disagree on lasting effects

18 studies
4,868 children with ADHD in a 2021 meta-analysis of methylphenidate taken for more than six months: a small, consistent drop in height and weight scores, with no clear effect of dose, formulation, or age

That 2021 meta-analysis, published in Neuroscience and Biobehavioral Reviews, concluded that long-term methylphenidate can reduce height and weight but that the effect sizes are small and may have minimal clinical impact for most children. FDA labeling puts the early effect in concrete terms: in children aged 7 to 10 who were followed for three years in the MTA study, those medicated seven days a week throughout the year grew about 2 cm less in height and gained about 2.7 kg less weight than unmedicated children, without evidence of a growth rebound during that period. The label adds that published data on amphetamines are more limited, but a similar effect is expected.

The Adult Height Question: Two Major Studies Disagree

Whether the early slowdown is temporary or permanent is where the evidence splits. The two largest long-term follow-ups reached different conclusions.

2.55 cmMTA: Treated vs. Negligible Use
4.06 cmMTA: Consistent vs. Negligible, 16 Years
No DifferenceRochester: Treated vs. Untreated

The Multimodal Treatment Study of ADHD (MTA) began as a randomized trial and then followed participants into adulthood. By about age 25, children who had used stimulants consistently or inconsistently were 2.55 cm shorter than those with negligible use, and consistent users were 2.36 cm shorter than inconsistent users. A later analysis of growth trajectories across 16 years found the consistent-use group, only 53 participants, ended up 4.06 cm (1.6 in) shorter than the negligible-use group. The researchers also reported that this extended medication use was not associated with lower symptom severity in adulthood, which they framed as a reason to weigh benefits and costs over time.

The Rochester study, published in Pediatrics in 2014, took a different approach. It followed 340 children with ADHD and 680 matched controls from a population-based birth cohort in Minnesota, using medical records and adult follow-up. Neither ADHD nor stimulant treatment was linked to differences in the size of the adolescent growth spurt or in adult height, and longer treatment wasn't associated with shorter adult height. Among boys, a longer duration of stimulant use before the growth spurt was linked to a later spurt, which our peak height velocity guide explains in more detail, but adult height still did not differ.

Why the studies can disagree. No trial has randomly assigned children to years of stimulant treatment versus none, so the long-term evidence is observational. In the MTA follow-up, families chose whether to continue medication after the original trial, and families who kept their child on treatment may differ in ways that also relate to growth. The consistent-use group was small. The Rochester cohort relied partly on medical records from children born between 1976 and 1982, when treatment patterns may have differed from today's. Both are credible studies, and the honest summary is that a lasting effect of around 1 to 1.5 inches is possible for children who stay on stimulants continuously for many years, but it has not been consistently shown.

What Parents Can Do

The goal is to catch a growth slowdown early, when there are the most options, without giving up treatment that helps. These are the practical steps that follow from the evidence.

Step 1
Track Height and Weight Over Time
Ask for height and weight at every medication visit, and keep your own record. Our home measuring guide shows how to get readings accurate enough to compare from one visit to the next.
Step 2
Watch the Growth Rate, Not One Number
A drop across percentile lines or a yearly growth rate that falls below the expected range for age matters more than any single measurement. Our growth velocity calculator turns two measurements into a yearly rate.
Step 3
Pay Attention to Appetite
Since reduced appetite is the leading explanation for slower growth, note whether your child is skipping meals or losing weight, and ask the prescriber how meal timing can work around the hours the medication is active.
Step 4
Ask About Options If Growth Slows
If growth falls off, the prescriber may review the dose, timing, planned breaks, or a different medication. FDA labeling notes treatment may need to be interrupted. Make these changes with the doctor, not on your own.

What about "drug holidays"? Some families pause stimulants on weekends or during school vacations. A 2015 review of 22 studies published between 1972 and 2013 found that 25% to 70% of families take such breaks, most often during school holidays, and reported some evidence that longer breaks were linked to better growth, while shorter breaks could help with sleep and appetite. The evidence is limited and mixed in quality, and breaks can bring back symptoms at home and in activities. A planned break is a reasonable topic to raise with your child's prescriber, especially if growth or appetite is a concern, but it should be a shared decision rather than a default.

What This Means For You

✓ Reasonable Ways to Use This
✓Expecting a modest slowdown in weight and height gain in the first one to three years of stimulant treatment
✓Asking for height and weight to be measured and plotted at every medication visit
✓Raising appetite, meal timing, or planned breaks with the prescriber if growth starts to fall off
✓Weighing a possible inch or so of adult height against the real benefits treatment brings your child, together with their doctor
⚠ Ways This Gets Misused
⚠Stopping or skipping a child's medication without talking to the prescriber
⚠Treating the MTA's 4 cm figure as what every medicated child will lose
⚠Assuming there's no effect at all and skipping growth checks
⚠Blaming the medication for short stature without checking family height, growth rate, and other causes

The practical takeaway: ADHD stimulants can slow growth a little, mostly in the first one to three years, and that early effect is well documented. Whether it leaves a lasting difference is unsettled: one major study found consistent long-term users ended up about 1 to 1.6 inches shorter, while another found no difference in adult height. Either way, the answer for most families is careful monitoring rather than avoiding treatment. Track your child's height accurately with our home measuring guide, check the yearly rate with our growth velocity guide, and if growth is slowing for any reason, see our guide on when to worry about a child's height.

Frequently Asked Questions

Does ADHD medication stunt growth?

It can slow growth modestly, mostly in the first one to three years. FDA labeling for methylphenidate describes about 2 cm less height gain over three years in children medicated seven days a week. Whether this affects adult height is unsettled: the MTA study found consistent long-term users ended up about 2.4 to 4 cm shorter, while a population-based Rochester study found no difference.

Will my child catch up in height after stopping ADHD medication?

The evidence is mixed. FDA labeling notes that children in the MTA study showed no growth rebound during the three-year period it describes, and the MTA's adult follow-up suggested some of the difference persisted. The Rochester cohort found no difference in adult height, which is consistent with catch-up. A 2015 review reported some evidence that longer breaks from medication were linked to better growth.

Do non-stimulant ADHD medications affect growth?

Most of the long-term growth research described here involves stimulants, especially methylphenidate. Non-stimulant options exist, and a prescriber can explain how each one's side effects, including any effect on appetite or weight, compare for your child's situation.

How often should my child's growth be checked on ADHD medication?

FDA labeling tells prescribers to closely monitor height and weight in children taking stimulants. In practice, that usually means measuring at every medication follow-up and plotting the results on a growth chart so changes in growth rate are visible over time. Ask your child's doctor what schedule they recommend.

Should we take weekends or summers off ADHD medication to protect growth?

Some families do, and a 2015 review found some evidence that longer breaks were linked to better growth. The evidence is limited, and breaks can bring back symptoms that affect home life, friendships, and activities. It's a reasonable option to discuss with the prescriber, particularly if growth or appetite is a concern, rather than a step to take on your own.

References

1
Young Adult Outcomes in the Follow-Up of the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder: Symptom Persistence, Source Discrepancy and Height Suppression Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, et al. Journal of Child Psychology and Psychiatry. 2017;58(6):663-678 pmc.ncbi.nlm.nih.gov/articles/PMC6168061
2
Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder Greenhill LL, Swanson JM, Hechtman L, Waxmonsky J, Arnold LE, Molina BSG, et al. Journal of the American Academy of Child and Adolescent Psychiatry. 2020 pubmed.ncbi.nlm.nih.gov/31421233
3
ADHD, Stimulant Treatment, and Growth: A Longitudinal Study Harstad EB, Weaver AL, Katusic SK, Colligan RC, Kumar S, Chan E, Voigt RG, Barbaresi WJ. Pediatrics. 2014;134(4):e935-e944 pmc.ncbi.nlm.nih.gov/articles/PMC4179095
4
Long Term Methylphenidate Exposure and Growth in Children and Adolescents With ADHD. A Systematic Review and Meta-Analysis Carucci S, Balia C, Gagliano A, Lampis A, Buitelaar JK, Danckaerts M, et al. Neuroscience and Biobehavioral Reviews. 2021;120:509-525 sciencedirect.com/science/article/pii/S0149763420305923
5
Ritalin (Methylphenidate Hydrochloride) Prescribing Information, Section 5.7: Long-Term Suppression of Growth in Pediatric Patients FDA-approved drug labeling medlibrary.org/lib/rx/meds/ritalin/page/2
6
Drug Holidays From ADHD Medication: International Experience Over the Past Four Decades Ibrahim K, Donyai P. Journal of Attention Disorders. 2015;19(7):551-568 doi.org/10.1177/1087054714548035

Increase Height Blog
Logo
Enable registration in settings - general
Shopping cart